CME Quote, Financials, Valuation and Earnings

Coinbase Global has a net margin of 58.22% compared to CME Group's net margin of 3.23%. CME Group's return on equity of 13.28% beat Coinbase Global's return on equity of 15.99%.

CME Group has a consensus price target of $271.59, signalling downside risk potential of -0.88%. On the other hand Coinbase Global has an analysts' consensus of $268.45 which suggests that it could fall by -12.95%. Given that Coinbase Global has more downside risk than CME Group, analysts believe CME Group is more attractive than Coinbase Global.

CME Group has a beta of 0.451, which suggesting that the stock is 54.901% less volatile than S&P 500. In comparison Coinbase Global has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

CME Group has a quarterly dividend of $1.25 per share corresponding to a yield of 3.87%. Coinbase Global offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CME Group pays 101.66% of its earnings as a dividend. Coinbase Global pays out -- of its earnings as a dividend.

CME Group quarterly revenues are $1.6B, which are smaller than Coinbase Global quarterly revenues of $2B. CME Group's net income of $956.2M is higher than Coinbase Global's net income of $65.6M. Notably, CME Group's price-to-earnings ratio is 27.56x while Coinbase Global's PE ratio is 57.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CME Group is 15.70x versus 11.99x for Coinbase Global. Usually stocks with elevated PS ratios are considered overvalued.

Intercontinental Exchange has a net margin of 58.22% compared to CME Group's net margin of 24.68%. CME Group's return on equity of 13.28% beat Intercontinental Exchange's return on equity of 10.23%.

CME Group has a consensus price target of $271.59, signalling downside risk potential of -0.88%. On the other hand Intercontinental Exchange has an analysts' consensus of $192.69 which suggests that it could grow by 7.99%. Given that Intercontinental Exchange has higher upside potential than CME Group, analysts believe Intercontinental Exchange is more attractive than CME Group.

CME Group has a beta of 0.451, which suggesting that the stock is 54.901% less volatile than S&P 500. In comparison Intercontinental Exchange has a beta of 1.116, suggesting its more volatile than the S&P 500 by 11.635%.

CME Group has a quarterly dividend of $1.25 per share corresponding to a yield of 3.87%. Intercontinental Exchange offers a yield of 1.04% to investors and pays a quarterly dividend of $0.48 per share. CME Group pays 101.66% of its earnings as a dividend. Intercontinental Exchange pays out 37.73% of its earnings as a dividend. Intercontinental Exchange's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but CME Group's is not.

CME Group quarterly revenues are $1.6B, which are smaller than Intercontinental Exchange quarterly revenues of $3.2B. CME Group's net income of $956.2M is higher than Intercontinental Exchange's net income of $797M. Notably, CME Group's price-to-earnings ratio is 27.56x while Intercontinental Exchange's PE ratio is 36.94x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CME Group is 15.70x versus 8.44x for Intercontinental Exchange. Usually stocks with elevated PS ratios are considered overvalued.

Nasdaq has a net margin of 58.22% compared to CME Group's net margin of 18.9%. CME Group's return on equity of 13.28% beat Nasdaq's return on equity of 11.5%.

CME Group has a consensus price target of $271.59, signalling downside risk potential of -0.88%. On the other hand Nasdaq has an analysts' consensus of $84.83 which suggests that it could fall by -1.47%. Given that Nasdaq has more downside risk than CME Group, analysts believe CME Group is more attractive than Nasdaq.

CME Group has a beta of 0.451, which suggesting that the stock is 54.901% less volatile than S&P 500. In comparison Nasdaq has a beta of 1.004, suggesting its more volatile than the S&P 500 by 0.362%.

CME Group has a quarterly dividend of $1.25 per share corresponding to a yield of 3.87%. Nasdaq offers a yield of 1.15% to investors and pays a quarterly dividend of $0.27 per share. CME Group pays 101.66% of its earnings as a dividend. Nasdaq pays out 48.43% of its earnings as a dividend. Nasdaq's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but CME Group's is not.

CME Group quarterly revenues are $1.6B, which are smaller than Nasdaq quarterly revenues of $2.1B. CME Group's net income of $956.2M is higher than Nasdaq's net income of $395M. Notably, CME Group's price-to-earnings ratio is 27.56x while Nasdaq's PE ratio is 39.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CME Group is 15.70x versus 6.38x for Nasdaq. Usually stocks with elevated PS ratios are considered overvalued.

S&P Global has a net margin of 58.22% compared to CME Group's net margin of 28.86%. CME Group's return on equity of 13.28% beat S&P Global's return on equity of 10.35%.

CME Group has a consensus price target of $271.59, signalling downside risk potential of -0.88%. On the other hand S&P Global has an analysts' consensus of $585.97 which suggests that it could grow by 16.22%. Given that S&P Global has higher upside potential than CME Group, analysts believe S&P Global is more attractive than CME Group.

CME Group has a beta of 0.451, which suggesting that the stock is 54.901% less volatile than S&P 500. In comparison S&P Global has a beta of 1.196, suggesting its more volatile than the S&P 500 by 19.592%.

CME Group has a quarterly dividend of $1.25 per share corresponding to a yield of 3.87%. S&P Global offers a yield of 0.74% to investors and pays a quarterly dividend of $0.96 per share. CME Group pays 101.66% of its earnings as a dividend. S&P Global pays out 29.44% of its earnings as a dividend. S&P Global's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but CME Group's is not.

CME Group quarterly revenues are $1.6B, which are smaller than S&P Global quarterly revenues of $3.8B. CME Group's net income of $956.2M is lower than S&P Global's net income of $1.1B. Notably, CME Group's price-to-earnings ratio is 27.56x while S&P Global's PE ratio is 39.61x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CME Group is 15.70x versus 10.80x for S&P Global. Usually stocks with elevated PS ratios are considered overvalued.